Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Use of bispecifics and CAR T cells in South America
Revolutionising myeloma treatment through immune profiling
Treating relapsed multiple myeloma outside of use of T-cell redirected therapies
Guiding transplant decisions in multiple myeloma with MRD
Revolutionising multiple myeloma treatment with CAR T-Cell therapies
Gaza's cancer patients: Navigating the dual struggle of illness and war
Laser oncosurgery - A new perspective in treating cancer
Cancer in emergencies: What can we do better to protect the most vulnerable?
Transforming cancer care through telemedicine
Powering equity in cancer care through digital health
ESMO and WCLC: Latest developments in EGFR mutated NSCLC